Gains and Losses of HLA Class II (DR) and CD4 in Atypical Hyperplasia, Carcinoma in situ and Infiltrating Ductal Carcinoma of the Breast

Gains and Losses of HLA Class II (DR) and CD4 in Atypical Hyperplasia, Carcinoma in situ and Infiltrating Ductal Carcinoma of the Breast

Aim: Breast cancer is a frequent cause of death among women with gynaecologic malignancies despite the introduction of combination chemotherapy. There is therefore a need for new therapeutic strategies for patients with breast cancer, such as cellular immunotherapy. In this immunohistochemical study...

Full description

Bibliographic Details
Main Authors: Demetrio Tamiolakis, Ioannis Venizelos, Maria Lambropoulou, Theodoros Jivannakis, Evagelia Seliniotaki, Panagiotis Tsikouras, Vasilios Limberis, Angelos Tsalkidis, Nikolas Papadopoulos
Format: Article
Language:English
Published: Karolinum Press 2004-01-01
Series:Acta Medica
Subjects:
HLA class II (DR)
CD4
Atypical ductal hyperplasia of the breast
Breast cancer
Online Access:https://actamedica.lfhk.cuni.cz/online_first/18059694.2018.101/

Internet

https://actamedica.lfhk.cuni.cz/online_first/18059694.2018.101/

Similar Items